These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9042653)

  • 1. The role of pulmonary surfactant in obstructive airways disease.
    Hohlfeld J; Fabel H; Hamm H
    Eur Respir J; 1997 Feb; 10(2):482-91. PubMed ID: 9042653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary surfactant in the respiratory tract].
    Calkovská A
    Cesk Fysiol; 2000 Aug; 49(3):145-51. PubMed ID: 11039244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease.
    Zhao CZ; Fang XC; Wang D; Tang FD; Wang XD
    Respir Med; 2010 Oct; 104(10):1391-5. PubMed ID: 20638828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of airway caliber by autonomic nerves in asthma and in chronic obstructive pulmonary disease.
    de Jongste JC; Jongejan RC; Kerrebijn KF
    Am Rev Respir Dis; 1991 Jun; 143(6):1421-6. PubMed ID: 2048831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant.
    Jarjour NN; Enhorning G
    Am J Respir Crit Care Med; 1999 Jul; 160(1):336-41. PubMed ID: 10390421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD.
    Pellegrino R; Sterk PJ; Sont JK; Brusasco V
    Eur Respir J; 1998 Nov; 12(5):1219-27. PubMed ID: 9864024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications.
    Lusuardi M; Capelli A; Carli S; Tacconi MT; Salmona M; Donner CF
    Respiration; 1992; 59 Suppl 1():28-32. PubMed ID: 1579729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mucociliary system of the lung--role of surfactants].
    Gehr P; Im Hof V; Geiser M; Schürch S
    Schweiz Med Wochenschr; 2000 May; 130(19):691-8. PubMed ID: 10846763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases.
    Banerjee R; Puniyani RR
    J Biomater Appl; 2000 Jan; 14(3):243-72. PubMed ID: 10656543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased airway resistance due to surfactant dysfunction can be alleviated with aerosol surfactant.
    Enhorning G; Yarussi A; Rao P; Vargas I
    Can J Physiol Pharmacol; 1996 Jun; 74(6):687-91. PubMed ID: 8909780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary surfactant maintains patency of conducting airways in the rat.
    Enhorning G; Duffy LC; Welliver RC
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):554-6. PubMed ID: 7842219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic and neurogenic mechanisms in obstructive airways disease.
    Bleecker ER
    Am J Med; 1986 Nov; 81(5A):93-102. PubMed ID: 2878614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of serum with lung surfactant extract in the bronchiolar and alveolar airway models.
    Nag K; Hillier A; Parsons K; Garcia MF
    Respir Physiol Neurobiol; 2007 Aug; 157(2-3):411-24. PubMed ID: 17350899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease.
    Wiggs BR; Bosken C; Paré PD; James A; Hogg JC
    Am Rev Respir Dis; 1992 Jun; 145(6):1251-8. PubMed ID: 1595987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous surfactant application in respiratory failure due to chronic obstructive pulmonary disease.
    Wirtz H; Habscheid W; Ertl G; Schmidt M; Kochsiek K
    Respiration; 1995; 62(3):157-9. PubMed ID: 7569338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic innervation of human airways: structure, function, and pathophysiology in asthma.
    van der Velden VH; Hulsmann AR
    Neuroimmunomodulation; 1999; 6(3):145-59. PubMed ID: 10213912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease.
    Postma DS; Kerstjens HA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S187-92. PubMed ID: 9817744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant effects on fluid-elastic instabilities of liquid-lined flexible tubes: a model of airway closure.
    Halpern D; Grotberg JB
    J Biomech Eng; 1993 Aug; 115(3):271-7. PubMed ID: 8231142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant and allergic airway inflammation.
    Winkler C; Hohlfeld JM
    Swiss Med Wkly; 2013; 143():w13818. PubMed ID: 23896983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of acute-phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome.
    Pires-Neto RC; Morales MM; Lancas T; Inforsato N; Duarte MI; Amato MB; de Carvalho CR; da Silva LF; Mauad T; Dolhnikoff M
    J Crit Care; 2013 Feb; 28(1):111.e9-111.e15. PubMed ID: 22835422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.